Risk Factors for Postrepair Elevated Mitral Gradient: A Post-hoc Analysis of a Randomized Trial
Makoto Hibino(St. Michael's Hospital), Subodh Verma(St. Michael's Hospital), C. David Mazer(St. Michael's Hospital), Benoit E. de Varennes(Royal Victoria Hospital), Rawan K. Rumman(St. Michael's Hospital), Asim N. Cheema(Southlake Regional Health Center), Hwee Teoh(St. Michael's Hospital), Bobby Yanagawa(St. Michael's Hospital), Arjun Pandey(University of Ottawa), Kim A. Connelly(St. Michael's Hospital), Gianluigi Bisleri(St. Michael's Hospital), Adrian Quan(St. Michael's Hospital), Yujiro Yokoyama(St. Luke's University Health Network), Nitish K. Dhingra(St. Michael's Hospital), Vincent Chan(University of Ottawa), Christopher Bonneau(McGill University), Raj Verma(Royal College of Surgeons in Ireland), Howard Leong‐Poi(St. Michael's Hospital)
Cited by 4
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Transcatheter Aortic Valve Implantation for the Treatment of Severe Symptomatic Aortic Stenosis in Patients at Very High or Prohibitive Surgical Risk
|Journal of the American College of Cardiology|2010|973
New Markers of Inflammation and Endothelial Cell Activation
|Circulation|2003|733
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
|New England Journal of Medicine|2024|693